×
Please click
here
if you are not redirected within a few seconds.
All
News
Images
Videos
Maps
Shopping
Books
Search tools
Recent
Recent
Past hour
Past 24 hours
Past week
Past month
Past year
Archives
Sorted by relevance
Sorted by relevance
Sorted by date
Do Options Traders Know Something About PhaseBio Pharmaceuticals (PHAS) Stock We Don't?
Yahoo News New Zealand
Investors need to pay close attention to for PhaseBio Pharmaceuticals (PHAS) stock based on the movements in the options market lately.
1 week ago
PhaseBio Files for Bankruptcy, Inks Deal to Sell Assets to Unnamed Company (Updated)
BioSpace
PhaseBio plans to file Chapter 11 bankruptcy and sell off its bentracimab assets under a stalking horse arrangement with an unnamed “large...
18 months ago
Orrick Advises SFJ Pharmaceuticals on Acquisition of Bentracimab Assets from PhaseBio
Orrick
Orrick advised SFJ on its acquisition of assets related to the drug Bentracimab from PhaseBio.
16 months ago
PhaseBio Files for Bankruptcy Following Blackstone-Backed Partner's Lawsuit
WSJ
PhaseBio Pharmaceuticals Inc., a publicly traded heart-disease drug developer, filed for chapter 11 bankruptcy protection weeks after being...
18 months ago
SFJ Pharmaceuticals Announces Closing of Transfer of Bentracimab Assets from PhaseBio Pharmaceuticals
Business Wire
SFJ Pharmaceuticals (“SFJ” or the “company”) today announced the closing of the sale and transfer of assets related to Bentracimab from...
16 months ago
Pharma industry mixed on outlook of decentralised trials
Clinical Trials Arena
Pharma and service providers discussed the rocky rollout of DCTs and strategies for moving forward at the Outsourcing Clinical Trials East...
11 months ago
Veralox Names PhaseBio's Jonathan Mow as New CEO after Raising $24 Million
citybiz
Frederick, Md.-based Veralox Therapeutics, a clinical-stage biotechnology firm targeting immune-mediated diseases such as Type-1 diabetes...
10 months ago
Bankrupt PhaseBio to Open Auction With Chiesi $100 Million Bid
Bloomberg Law News
PhaseBio Pharmaceuticals Inc. plans to start a bankruptcy auction sale of its antibody drug bentracimab with Italy-based Chiesi Farmaceutici...
18 months ago
PhaseBio Announces Positive Results from Phase 2b Trial for Bentracimab
BioBuzz
PhaseBio Pharmaceuticals, Inc. (Nasdaq: PHAS) announced the complete results from its Phase 2b clinical trial of bentracimab that were...
28 months ago
Alfasigma acquires the European license for bentracimab from PhaseBio
PR Newswire
PRNewswire/ -- Alfasigma has entered into an exclusive licensing agreement with PhaseBio Pharmaceuticals, Inc. (Nasdaq: PHAS),...
34 months ago